ABOUT GMDX

Over a decade of pioneering deaminase science

GMDx Genomics is a Melbourne-based precision-oncology company. Building on more than a decade of foundational research into how the immune system shapes the genome, the company has turned deaminase mutation science into an AI-enabled platform, a validated body of clinical evidence, and a globally protected IP estate.